DiLumen EIP featured in New York-Presbyterian Hospital publication.
“Pipeline developments include advanced tools that will provide better surgical capabilities,” says Dr. Milsom.
Dr. Milsom stresses that their goals are to make gastrointestinal therapies not only safer, but also less expensive.
Don’t miss the next blog newsletter, sign up with your e-mail right here.
New York-Presbyterian: DiLumen Endolumenal Interventional Platform (EIP)
CE marking granted: DiLumen is selling in Europe
We are happy to report that we have received CE marking.
Here we tell you a bit about what the CE mark stands for..
Having CE marking for our DiLumen enables us to market this product in Europe.
Don’t miss the next blog newsletter, sign up with your e-mail right here.
Amazon Echo and DiLumen C2
We are happy to show you a new video with the the DiLumen product line.
Here we report about how surgeons and endoscopists can use our DiLumen range of products.
Endoscopic submucosal dissection (ESD) with DiLumen C2 ensures complete positioning of an endoscope in the large intestine.
Don’t miss the next blog newsletter, sign up with your e-mail right here.
Testimonial
With more extensive use of DiLumen, its true potential is being realized, validating our goal of shifting the paradigm for colon disease intervention from the traditional surgical approach to a truly minimally invasive one that utilizes novel endolumenal-based technology. This shift will increase safety and patient recovery time as well as significantly reduce costs.
In more than 100 therapeutic procedures we have been able to demonstrate that the usage of the DiLumen technology can avoid open surgical procedures.